Nutritional and Metabolic Diseases

441 trials 157 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Efficacy And Safety of MET097 Once Weekly In People With Overweight or Obesity (VESPER-4) Recruiting

2025-523974-18-00 Obesity 5 2026-04-30
A research study to evaluate the safety of NNC1679-0001 when given to healthy participants and participants with T2DM Recruiting

2025-523304-68-00 Healthy participants and participants with type 2 diabe 1 2026-04-30
AMAZE 12: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight maintain their weight loss Recruiting

2025-523804-62-00 Obesity 5 2026-04-28
A research study to compare blood levels of cagrilintide after multiple doses of different versions of cagrilintide in adults with overweigh… Recruiting

2025-521384-12-00 obesity 2 2026-04-27
The SEMAFOOT2 Pilot. Effect of semaglutide on healing of foot ulcers in type 2 diabetes patients. A Pilot study. Recruiting

2023-504913-65-01 Type 2 diabetes, Diabetic foot ulcer 4 2026-04-24
A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity Recruiting

2025-524206-15-00 Obesity 3 2026-04-24
SAFEGUARD (SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes) Study Recruiting

2025-521560-36-00 Type 1 Diabetes 4 2026-04-22
Guselkumab intervention and diet evaluation for pouchitis Recruiting

2025-521683-35-00 Pouchitis 6 2026-04-21
AMAZE 5: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose… Recruiting

2024-520444-42-00 Overweight or obesity, and knee osteoarthritis 5 2026-04-15
AMAZE 6: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose… Recruiting

2024-520445-23-00 Overweight or obesity, and knee osteoarthritis 5 2026-04-15
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes ( ENLIGHTEN-1). Recruiting

2025-523657-34-00 Obesity 5 2026-04-13
A Study of Eloralintide (LY3841136) in Participants with Obesity or Overweight, and Type 2 Diabetes (ENLIGHTEN-2) Recruiting

2025-523658-15-00 Obesity 5 2026-04-10
Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health Recruiting

2025-522920-28-00 Obesity, CCI, CCI 3 2026-04-10
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes Recruiting

2025-521595-55-00 Type 2 Diabetes 3 2026-03-25
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2026-03-24
Impact of Early Thyroid Hormone Replacement on Kidney Function and Health-Related Quality of Life in Patients at Risk of Postoperative Hypot… Recruiting

2025-524175-23-00 Hypothyroidism 6 2026-03-12
A study to test the safety and efficacy of the study drug in patients with low blood sugar caused by hormones made by their tumor Recruiting

2024-515447-36-00 Tumor-associated hyperinsulinism 5 2026-03-10
COMPARISON OF ZINC ACETATE DOSE REGIMENS (GALZIN VS. ET-700) FOR THE TREATMENT OF WILSON DISEASE: A PHARMACODYNAMIC 64CUCL2 PET/CT STUDY IN … Recruiting

2025-523372-24-00 Wilson's Disease 4 2026-03-10
FINE-START; A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the eff… Recruiting

2025-523075-32-00 chronic kidney disease 5 2026-03-09
A trial to evaluate the efficacy and safety of oral controlled-ileal-release nicotinic acid (CIR-NA) for inducing remission in subjects with… Recruiting

2024-519903-88-00 Prediabetes 4 2026-03-03
The REVERT-PREDIABETES trial Recruiting

2025-522970-35-00 Coronary artery disease 11 2026-03-03
A phase 2, randomized, double-blind study of S-606001 as an add-on to enzyme replacement therapy in patients with late-onset Pompe disease. Recruiting

2025-522146-40-00 Late-onset Pompe disease. 4 2026-02-12
Finding treatments to slow the progression of chronic kidney disease Recruiting

2024-520253-21-00 Chronic Kidney Disease 5 2026-02-02
A Phase 3 Study of JNT-517 in Participants with Phenylketonuria Recruiting

2024-519554-37-00 Phenylketonuria 5 2026-01-16